Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01083043 · ClinicalTrials.gov registry record
Continuous Glucose Monitoring in Type 2 Diabetes Mellitus
A clinical trial, sponsored by NYU Langone Health.
- Completed
- Registry status
- 28
- Enrollment target
NCT01083043 is a clinical trial that has completed, run by NYU Langone Health. The registered enrollment target is 28 participants.
The verdict
NCT01083043 has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- 28 participants
- Enrollment target
Study Summary
It is well known that lowering average blood glucose decreases the risk of diabetic complications involving the small vessels, such as those found in the eyes, nerves and kidney. It is less clear however, if controlling fluctuations in blood glucose will further help to prevent such complications. The purpose of this study is to examine the relationship between extreme fluctuations in glucose and damage to the blood vessel lining.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2006-12 |
| Est. Completion | 2011-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01083043
The ClinicalTrials.gov registry entry for NCT01083043 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01083043 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01083043 about?
NCT01083043 is a clinical study titled "Continuous Glucose Monitoring in Type 2 Diabetes Mellitus". It is well known that lowering average blood glucose decreases the risk of diabetic complications involving the small vessels, such as those found in the eyes, nerves and kidney. It is less clear however, if controlling fluctuations in blood glucose will further help to prevent such complications. ...
What is the current status of trial NCT01083043?
This trial is currently completed. The enrollment target is 28 participants. The study started on 2006-12. Estimated completion is 2011-03.
Who is sponsoring clinical trial NCT01083043?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.